DAM
ALXN

Delta Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Delta Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15
Closed -$1K – 647
2018
Q4 		$1K Hold
15
– – ﹤0.01% 648
2018
Q3 		$2K Hold
15
– – ﹤0.01% 632
2018
Q2 		$2K Hold
15
– – ﹤0.01% 621
2018
Q1 		$2K Hold
15
– – ﹤0.01% 618
2017
Q4 		$2K Hold
15
– – ﹤0.01% 620
2017
Q3 		$2K Hold
15
– – ﹤0.01% 599
2017
Q2 		$2K Hold
15
– – ﹤0.01% 567
2017
Q1 		$2K Buy
+15
New +$1.93K ﹤0.01% 584

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Delta Asset Management's ALXN Position: Q1 2019 in Review

Delta Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q1 2019, closing a stake of 15 shares — an estimated $1K sold.

Delta Asset Management first reported a position in ALXN in Q1 2017 and held it in 8 quarters. The position peaked at $2K in Q3 2018. 612 funds tracked by Wall St. Rank hold ALXN as of Q1 2019.

  • Delta Asset Management reported no remaining Alexion Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Delta Asset Management sold 15 Alexion Pharmaceuticals shares in Q1 2019, an estimated $1K.
  • Delta Asset Management first reported a position in Alexion Pharmaceuticals in Q1 2017 and held it in 8 quarters.
  • Delta Asset Management's Alexion Pharmaceuticals position peaked at $2K in Q3 2018.
  • 612 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2019.

Based on Delta Asset Management's 13F filing for Q1 2019, filed 30 Apr 2019.